Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zoungas, Sophia
STAREE, NCT02099123: A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly	Active, not recruiting	4	9971	RoW	Atorvastatin, Lipitor, , , Cadivast, Caduet, Lorstat, Torvastat, Trovas, Atorachol, Cadatin, Placebo (for Atorvastatin), no other names	Monash University, National Health and Medical Research Council, Australia, National Heart Foundation, Australia	Independent Living, Disability Free Survival, Elderly, Healthy	12/25	12/25
STAREE-Mind, NCT05586750: Statins in Reducing Events in the Elderly Mind () Imaging Substudy	Active, not recruiting	4	341	RoW	Atorvastatin 40 Mg Oral Tablet, Placebo	Monash University, National Health and Medical Research Council, Australia	Dementia, Mixed, Dementia, Vascular, Dementia of Alzheimer Type, Cognitive Decline, White Matter Hyperintensity, Aging, Neuro-Degenerative Disease	09/26	09/26
START, NCT05345327: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes	Recruiting	3	994	RoW	Dapagliflozin, Metformin	The George Institute, The University of New South Wales, Monash University, University of Sydney	Type 2 Diabetes	06/26	06/26